Gilead Sciences On The Rise. But Has It Peaked?
Article By:
Jim Van Meerten
Read
Wednesday, September 11, 2013 7:00 AM EDT
Jim Van Meerten examines which S&P 100 company had the highest Weighted Alpha and Gilead Sciences (GILD) came out on top with a score of 98.30+. The stock is up 30% and still rising. But does it have any steam left?
No Correlation At All??
Article By:
Bruce Krasting
Read
Friday, September 6, 2013 8:25 AM EDT
Tom Perez:, the Secretary of Labor says there is no correlation between Obamacare and employee hours being cut. Smoke and mirrors or the truth?
Black Or White?
Article By:
Bruce Krasting
Read
Saturday, August 24, 2013 7:01 AM EDT
Black or white? The Malayan Tapir has some of both. So does the Bernanke Taper Plan.
Senior Housing Properties - Chart Of The Day
Article By:
Jim Van Meerten
Read
Monday, April 8, 2013 4:55 PM EDT
Housing units for the elderly and retired should be a growth industry. Senior Housing Properties (SNH) was up 17 times for a gain of 8.50% in the last month.
In this article: SNH
Novavax Buy Signals
Article By:
Jim Van Meerten
Read
Monday, April 8, 2013 4:55 PM EDT
TalkMarkets Contributor Jim Van Meerten adds Novavax (NVAAX) to the Barchart Van Meerten Speculative portfolio.
In this article: NVAX
Accelerate Diagnostics: Chart Of The Day
Article By:
Jim Van Meerten
Read
Wednesday, March 27, 2013 4:52 PM EDT
In the last quarter, AXDX advanced in 25 sessions for a gain of 113%
New Use For Paxil Could Mean Potential Blockbuster For GlaxoSmithKline
Article By:
Vivian Lewis
Read
Wednesday, December 19, 2012 6:00 AM EDT
GlaxoSmithKline's well known drug for depression, Paxil, is found to be successful in treating diabetes. A new use for an old drug could mean massive profits for GSK.
In this article: GSK